findmyKOL

Warren Manning, MD

Basic profile

Beth Israel Deaconess Medical Center

ORCIDNPI
RegionBoston, MA · NortheastSpecialtyCardiovascular DiseaseFocusCardiology
Last active 2012findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationSee ScholarshipOnline presenceNot yet checkedPaymentsNone reportedNIH funding1990–2012Why? →

Warren Manning is a Cardiology physician affiliated with Beth Israel Deaconess Medical Center. OpenAlex indexes 796 publications with 42,528 citations (h-index 102); ClinicalTrials.gov lists 1 registered study matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Cardiovascular Disease profiles in the findmyKOL directory.

Overview

Scholarship

indexed output and impact (OpenAlex)
796publications

Distinct works indexed by OpenAlex, matched via ORCID.

42,528citations

Total citations across indexed works.

102h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1clinical trials

Investigator role on registered studies.

View trials
5NIH grants · 1990–2012

Federally funded research awards.

View funding

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    82.1%
    Statin20.5%
    Atorvastatin Calcium61%Rosuvastatin Calcium28%Pravastatin Sodium12%
    Part D<11 patients
    Beta blocker19.8%
    Metoprolol Succinate72%Atenolol10%Sotalol8%Metoprolol Tartrate7%Labetalol Hcl4%
    Part D<11 patients

    + 9 more classes in this area

  • Blood & clotting

    16.2%
    Factor Xa inhibitor13.5%
    Eliquis89%Xarelto11%
    Part D<11 patients
    P2Y12 inhibitor1.8%
    Clopidogrel100%
    Part D11 patients

    + 1 more class in this area

  • Anti-infectives

    1.8%
    Penicillins with extended spectrum1.8%
    Amoxicillin100%
    Part D17 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

5 NIH research awards on record, funded 19902012 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”